All three tenses have at least two readings, so the archetype blend applies as printed.
Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.
What did they actually do?
Has it survived what it has been through?
2 warning events since 2024; the latest 2026-10-16.
From the record
Health In Tech, Inc.'s filings since 2024 show 2 warning events: a notice about its exchange listing (8-K item 3.01, 2 times, the latest 2026-10-16) (its current reports).
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What has it actually done, year after year?
+31.9% a year over 3 filed years; profit years unseen.
From the record
Health In Tech, Inc.'s 3 filed years say what it did: revenue went from $19 million in fiscal 2023 to $33 million in fiscal 2025, up 31.9% a year; it rose in 2 of 2 years; it never fell from a peak (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How has it treated the people who own it?
Share count grew 7.6% a year. 0% of cash flow returned. Insiders: 6 sales, 0 purchases.
From the record
Over the fiscal year to 2025-12-31, Health In Tech, Inc.'s diluted share count grew about 7.6% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 6 sales (3 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-11-05 (their Form 4 filings).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are they doing right now?
Is it financially healthy right now?
ROE 7%: 7¢ of profit per shareholder dollar. Leverage 26%: owes 26¢ per asset dollar.
From the record
Return on equity: in the fiscal year ended 2025-12-31, Health In Tech, Inc. earned about 7 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 91 cents per dollar of everything the company owns. Leverage: it owed about 26 cents per dollar of assets, and net share issuance: its share count grew 7.6% over the year (the filed statements).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
How strong is its position in its industry?
bottom 44% of 30 in its family; net margin 3.8%.
From the record
Health In Tech, Inc.'s standing among 30 graded names in its industry family: revenue of $33 million in fiscal 2025 ranks in the bottom 6% by size; a net margin of 3.8% ranks in the bottom 45%; revenue growth of 31.9% a year over the last 2 filed years ranks in the top 18% (its annual reports).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are the people in charge doing?
bottom 11% of 21 in its family for leadership; chief executive since 2026.
From the record
Health In Tech, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Shrestha, Sanjay K (Chief Executive Officer, as filed), filing under that title since 2026-10-22, under a month (bottom 3% of its family); most of the 12 officers and directors filing now have filed since the record of its people begins (2024-12-20), a floor of 1.8 years the record cannot see past, so that part is not read; 8 officer or director changes were reported on Form 8-K since 2023-11-13, against the 12 people in charge now (bottom 19%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What are they set up to do next?
How much room does it have to grow?
top 27% of 29 in its family for room to expand.
From the record
Health In Tech, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $8 million against no long-term debt tagged leaves 33.2% of its assets as net cash, top 16% of its family; cash from operations less capital spending is 9.4% of revenue (bottom 48%); a gross margin of 62.8% (top 19%); research spending of 4.7% of revenue (top 21%) (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
What could actually drive growth from here?
top 38% of 29 in its family for growth drivers.
From the record
Health In Tech, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 31.9% a year over the last three filed years against 31.9% over all 3, speeding up (top 43% of its family); the newest year grew 71.1% (top 2%); research spending grew -11.5% a year (bottom 31%) (its annual reports). Health In Tech, Inc. reported 2 product lines in fiscal 2025: Revenues From Fees at $26 million (79%), Revenues From Underwriting Modeling ICE at $7 million (21%); 2 of 2 grew against the year before (its annual report).
What it rests on
A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.
Did its newest year beat what its own record pointed to?
SI estimate 5.2/10, confidence 20 of 100 (family median).
SI estimate Inferred, not read as filed
From the record
SI estimate, not a filed reading: Health In Tech, Inc.'s expectations vs reality is put at 5.2 of 10 with a confidence of 20 of 100, because the record does not carry four filed years of revenue and two of the three parts: revenue against the prior pace, earnings against the prior average, the margin change, so the desk assumes the typical reading of its industry family, the median of 25 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.
The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made